Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiki Niimi

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Journal of Neuroendovascular Therapy|October 20, 2025
Contact Aspiration Combined with a Stent Retriever versus Contact Aspiration Alone in Mechanical Thrombectomy for Acute Ischemic Strokes: A Nationwide Analysis Using the Diagnosis Procedure Combination DatabaseSaki Nakashima, Shuhei Egashira, Shotaro Aso, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 20, 2025
Real-world lecanemab adoption in Japan 1 year after launch: Insights from 311 specialists on infrastructure and reimbursement barriersKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Nature Communications|August 5, 2022
Multi-cohort and longitudinal Bayesian clustering study of stage and subtype in Alzheimer's diseaseKonstantinos Poulakis, Joana B Pereira, J-Sebastian Muehlboeck, et al.
The Clinical Neuropsychologist|November 19, 2025
Lecanemab for posterior cortical atrophy: Two contrasting casesKazuto Katsuse, Kazuo Kakinuma, Yoshiki Niimi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 29, 2021
Predicting amyloid risk by machine learning algorithms based on the A4 screen data: Application to the Japanese Trial-Ready Cohort studyKenichiro Sato, Ryoko Ihara, Kazushi Suzuki, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 28, 2016
Phase II Trial of Intravenous Low-Dose Granulocyte Colony-Stimulating Factor in Acute Ischemic StrokeAtsushi Mizuma, Toru Yamashita, Syoichiro Kono, et al.
Clinical Neurology and Neurosurgery|September 17, 2013
Clinical and radiological impact of liver transplantation for brain in cirrhosis patients without hepatic encephalopathyTetsuro Ishihara, Mizuki Ito, Yoshiki Niimi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 22, 2025
Immediate reactions to amyloid PET disclosure in Japanese older adults without dementiaKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 15, 2026
Characterizing Japanese older adults without dementia by amyloid PET status: A comparative study of amyloid-positive and amyloid-negative groups from Japanese trial-ready cohort studySaki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
Alzheimer'S Research & Therapy|May 22, 2024
Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderlyYoshiki Niimi, Shorena Janelidze, Kenichiro Sato, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Journal of Neuroendovascular Therapy|October 20, 2025
Contact Aspiration Combined with a Stent Retriever versus Contact Aspiration Alone in Mechanical Thrombectomy for Acute Ischemic Strokes: A Nationwide Analysis Using the Diagnosis Procedure Combination DatabaseSaki Nakashima, Shuhei Egashira, Shotaro Aso, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 20, 2025
Real-world lecanemab adoption in Japan 1 year after launch: Insights from 311 specialists on infrastructure and reimbursement barriersKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Nature Communications|August 5, 2022
Multi-cohort and longitudinal Bayesian clustering study of stage and subtype in Alzheimer's diseaseKonstantinos Poulakis, Joana B Pereira, J-Sebastian Muehlboeck, et al.
The Clinical Neuropsychologist|November 19, 2025
Lecanemab for posterior cortical atrophy: Two contrasting casesKazuto Katsuse, Kazuo Kakinuma, Yoshiki Niimi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 29, 2021
Predicting amyloid risk by machine learning algorithms based on the A4 screen data: Application to the Japanese Trial-Ready Cohort studyKenichiro Sato, Ryoko Ihara, Kazushi Suzuki, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 28, 2016
Phase II Trial of Intravenous Low-Dose Granulocyte Colony-Stimulating Factor in Acute Ischemic StrokeAtsushi Mizuma, Toru Yamashita, Syoichiro Kono, et al.
Clinical Neurology and Neurosurgery|September 17, 2013
Clinical and radiological impact of liver transplantation for brain in cirrhosis patients without hepatic encephalopathyTetsuro Ishihara, Mizuki Ito, Yoshiki Niimi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 22, 2025
Immediate reactions to amyloid PET disclosure in Japanese older adults without dementiaKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 15, 2026
Characterizing Japanese older adults without dementia by amyloid PET status: A comparative study of amyloid-positive and amyloid-negative groups from Japanese trial-ready cohort studySaki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
Alzheimer'S Research & Therapy|May 22, 2024
Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderlyYoshiki Niimi, Shorena Janelidze, Kenichiro Sato, et al.
Pageof 8